The largest database of trusted experimental protocols

Spss statistical software v 22

Manufactured by IBM
Sourced in United States

SPSS Statistical Software (v.22) is a comprehensive statistical analysis tool designed for data management, analysis, and reporting. It provides a wide range of statistical techniques, including descriptive statistics, bivariate analysis, and advanced multivariate methods. The software is used by researchers, analysts, and organizations to gain insights from their data.

Automatically generated - may contain errors

37 protocols using spss statistical software v 22

1

Predictors of Fatty Liver Index

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses of these data were conducted with SPSS (IBM SPSS Statistical Software V 22, Chicago, IL). Homogeneity of the between-group data was evaluated with Levene's test of equality of variances reporting no significant differences. Independent samples t-test was completed for between sex group differences. The within group differences were conducted using analysis of variance (ANOVA) between each time point, 0 M, 3 M, and 6 M. Linear regression modeling was used with all the time points combined (n = 30) to determine the primary noninvasive predictors of the FLI which included total fat mass, trunk fat mass, nontrunk fat mass, body fat percentage, and total weight. Leptin and soluble leptin receptor were excluded from the linear regression model testing as they are central to the independent variable we set out to predict. Significance was set at a two-tailed alpha of p ≤ 0.05.
+ Open protocol
+ Expand
2

Estimating Educational Inequalities in Chronic Illness

Check if the same lab product or an alternative is used in the 5 most similar protocols
To estimate educational inequalities in the relative differences in labour force participation among persons with a chronic illness, a counterfactual scenario was introduced. In this scenario, it is assumed that the relative difference in labour force participation between those with a chronic illness and those without in the lower educational group can be reduced to the relative difference observed in the higher educational group.26 (link) The estimation of the excess relative difference in paid employment for chronic illness status in lower educated workers is a fair reflection of educational inequalities between low and high-educated persons. The Cox proportional hazard model was used to estimate this excess relative difference by the formula: (bèta for relative difference in the low-educated group—beta for relative difference in the high-educated group)/(bèta of the relative difference in the low-educated group).
The main analysis was performed using Stata statistical software V.14 (StataCorp). The estimates of paid employment per country and the trend analysis were conducted in IBM SPSS statistical software V.22 (SPSS).
+ Open protocol
+ Expand
3

Workplace Factors and Mental Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were performed using IBM SPSS statistical software (v22). Descriptive statistics, Chi-square tests, 2-sample independent t-tests and one way ANOVAS were used to examine how representative the current sample was compared to previously published population-based samples. The association between manager psychosocial safety climate (MPSC), manager behaviour (MB), and each of the mental health outcomes was examined using linear regression. Scores for MPSC and MB were each divided into five evenly sized groups (quintiles). Multiple hierarchical linear regression analyses were conducted to assess whether either workplace variable (MPSC and MB) were significant independent predictors of employee mental health outcomes (symptoms of CMD and mental well-being) after adjusting for relevant sociodemographic variables (age range, gender, location, type of employment).
+ Open protocol
+ Expand
4

Evaluation of Anti-inflammatory Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
All results were presented as the mean ± standard deviation (SD). Statistical comparisons were evaluated by one-way analysis of variance and LSD test, with SPSS Statistical Software (v.22; IBM, Chicago, IL, USA). P<0.05 was considered as statistically significant.
+ Open protocol
+ Expand
5

Tomm34 and p16 Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data was analyzed by IBM SPSS statistical software V22 (IBM Corporation, United States). The χ2 test was utilized to assess the associations between the expression of Tomm34 or p16 and clinical characteristics of patients. Survival estimates were analyzed by Kaplan-Meier method with significance determined by the log rank test. A p value less than 0.05 (two-sided) was considered significant.
+ Open protocol
+ Expand
6

Posterior Opening Gap Correction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were performed using the SPSS statistical software v.22 (IBM, New York, USA), in which a significance threshold of 0.05 was set for all statistical comparisons. The Analysis of Variance (ANOVA) test was conducted to verify the change depending on the correction amount of the posterior opening gap. The values obtained for the uni- and bi-planar osteotomy were compared by the independent t-test. Sample size was calculated from following values (α error 0.05, power 0.85, effect size 0.5: sample size 31).
+ Open protocol
+ Expand
7

Comparative Analysis of Treatment Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Results were presented as Mean±SD. SPSS Statistical Software (v.22; IBM, Chicago, IL, USA) was used to analyze all data. One-way ANOVA and LSD test were used to compare among groups. P<0.05 was considered as the statistical significance.
+ Open protocol
+ Expand
8

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this work, the experimental data were presented as mean ± SD and statistically analyzed by one-way ANOVA and LSD test using SPSS Statistical Software (v.22; IBM, Chicago, IL, USA). p < 0.05 was statistically significant.
+ Open protocol
+ Expand
9

Descriptive Statistical Analysis of Biological Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistical analysis was reported as absolute frequencies. Mean values were given with the SD, median values were given with the range. One-way analysis of variance was used for comparison of baseline characteristics at start of first biological therapy. Fisher's exact test was used to compare achievement of inactive disease. To describe differences in drug discontinuation, a log-rank test based on Kaplan-Meier survival was performed. p Values less than 0.05 were considered statistically significant with a two-sided test performed.
Statistical analysis was performed with SPSS Statistical software, V.22 (IBM, USA).
+ Open protocol
+ Expand
10

Tissue and Plasma Analyses Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mean normalized tissue Western blot protein O.D., tissue NE, and plasma glucose measures were evaluated between treatment groups within each sex by three-way analysis of variance and Student-Newman-Keuls post-hoc test, using IBM SPSS Statistical Software V22. Differences of p<0.05 were considered significant. In each figure, statistical differences between specific pairs of treatment groups determined by post-hoc analysis are denoted with the following symbols: *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!